Magellan Health Services Inc. (NASDAQ:MGLN) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Thursday. The firm presently has a $77.00 target price on the stock. Zacks Investment Research’s price target indicates a potential upside of 11.74% from the company’s previous close. According to Zacks, […]
